A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation (Q36608816)
Jump to navigation
Jump to search
scientific article published on 4 December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation |
scientific article published on 4 December 2007 |
Statements
1 reference
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation (English)
1 reference
M Scartozzi
1 reference
S Cascinu
1 reference
R Berardi
1 reference
S Salvagni
1 reference
G D Beretta
1 reference
V Catalano
1 reference
F Pucci
1 reference
A Sobrero
1 reference
P Tagliaferri
1 reference
R Labianca
1 reference
F Crocicchio
1 reference
E Mari
1 reference
A Ardizzoni
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference